学术探索
学术期刊
新闻热点
数据分析
智能评审

THE ASSESSMENT OF ACE ACTIVITY IN MAN FOLLOWING ANGIOTENSIN-I CHALLENGES - A COMPARISON OF CILAZAPRIL, CAPTOPRIL AND ENALAPRIL

被引：20
作者：
ESSIG, J
BELZ, GG
WELLSTEIN, A
机构：
[1] ZEKAPHA GMBH,ZENTRUM KARDIOVASC PHARMAKOL,WIESBADEN,FED REP GER
[2] UNIV FRANKFURT,ZENTRUM PHARMAKOL,D-6000 FRANKFURT 1,FED REP GER
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷
关键词：
D O I：
10.1111/j.1365-2125.1989.tb03485.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S217 / S223
页数：7
相关论文
共 15 条
  • [1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [2] HEMODYNAMIC-RESPONSES TO ANGIOTENSIN-I IN NORMAL VOLUNTEERS AND THE ANTAGONISM BY THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL
    BELZ, GG
    ESSIG, J
    WELLSTEIN, A
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (02) : 219 - 224
  • [3] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I
    BIOLLAZ, J
    BURNIER, M
    TURINI, GA
    BRUNNER, DB
    PORCHET, M
    GOMEZ, HJ
    JONES, KH
    FERBER, F
    ABRAMS, WB
    GAVRAS, H
    BRUNNER, HR
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) : 665 - 670
  • [4] THE EFFECT OF THE CONVERTING ENZYME-INHIBITOR HOE-498 ON THE RENIN-ANGIOTENSIN SYSTEM OF NORMAL VOLUNTEERS
    BUSSIEN, JP
    NUSSBERGER, J
    PORCHET, M
    WAEBER, B
    BRUNNER, HR
    PERISIC, M
    TANSEY, MJ
    BOMM, M
    HAJDU, P
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 329 (01) : 63 - 69
  • [5] PHARMACOKINETICS OF THE CONVERTING-ENZYME-INHIBITOR CILAZAPRIL IN NORMAL VOLUNTEERS AND THE RELATIONSHIP TO ENZYME-INHIBITION - DEVELOPMENT OF A MATHEMATICAL-MODEL
    FRANCIS, RJ
    BROWN, AN
    KLER, L
    DAMORE, TF
    NUSSBERGER, J
    WAEBER, B
    BRUNNER, HR
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (01) : 32 - 38
  • [6] DURATION OF ACTION AND SHORT-TERM HORMONAL RESPONSES TO ENALAPRIL (MK-421) IN NORMAL SUBJECTS
    GIVEN, BD
    TAYLOR, T
    HOLLENBERG, NK
    WILLIAMS, GH
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (03) : 436 - 441
  • [7] CARDIOVASCULAR EFFECTS OF THE NEW ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR, CILAZAPRIL, IN ANESTHETIZED AND CONSCIOUS DOGS
    HOLCK, M
    FISCHLI, W
    HEFTI, F
    GEROLD, M
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1986, 8 (01) : 99 - 108
  • [8] CLINICAL PHARMACOKINETICS OF THE ANGIOTENSIN CONVERTING ENZYME-INHIBITORS - A REVIEW
    KUBO, SH
    CODY, RJ
    [J]. CLINICAL PHARMACOKINETICS, 1985, 10 (05) : 377 - 391
  • [9] BIOLOGICAL PROPERTIES OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL
    NATOFF, IL
    NIXON, JS
    FRANCIS, RJ
    KLEVANS, LR
    BREWSTER, M
    BUDD, J
    PATEL, AT
    WENGER, J
    WORTH, E
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (03) : 569 - 580
  • [10] ENZYMES OF THE RENIN-ANGIOTENSIN SYSTEM AND THEIR INHIBITORS
    ONDETTI, MA
    CUSHMAN, DW
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 : 283 - 308
12